These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 29042779)

  • 21. Relationship between major depressive disorder and associated painful physical symptoms: analysis of data from two pooled placebo-controlled, randomized studies of duloxetine.
    Robinson MJ; Sheehan D; Gaynor PJ; Marangell LB; Tanaka Y; Lipsius S; Ohara F; Namiki C
    Int Clin Psychopharmacol; 2013 Nov; 28(6):330-8. PubMed ID: 23873291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Duloxetine for the treatment of major depressive disorder.
    Nemeroff CB; Schatzberg AF; Goldstein DJ; Detke MJ; Mallinckrodt C; Lu Y; Tran PV
    Psychopharmacol Bull; 2002; 36(4):106-32. PubMed ID: 12858150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
    Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duloxetine in treatment of anxiety symptoms associated with depression.
    Dunner DL; Goldstein DJ; Mallinckrodt C; Lu Y; Detke MJ
    Depress Anxiety; 2003; 18(2):53-61. PubMed ID: 12964171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Duloxetine 60 mg once daily in the treatment of milder major depressive disorder.
    Perahia DG; Kajdasz DK; Walker DJ; Raskin J; Tylee A
    Int J Clin Pract; 2006 May; 60(5):613-20. PubMed ID: 16700869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.
    Khan A; Bose A; Alexopoulos GS; Gommoll C; Li D; Gandhi C
    Clin Drug Investig; 2007; 27(7):481-92. PubMed ID: 17563128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized, single-blind, comparison of duloxetine with bupropion in the treatment of SSRI-resistant major depression.
    Rosso G; Rigardetto S; Bogetto F; Maina G
    J Affect Disord; 2012 Jan; 136(1-2):172-176. PubMed ID: 21862138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unexplained Painful Physical Symptoms in Patients with Major Depressive Disorder: Prevalence, Pathophysiology and Management.
    Jaracz J; Gattner K; Jaracz K; Górna K
    CNS Drugs; 2016 Apr; 30(4):293-304. PubMed ID: 27048351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features.
    Mallinckrodt CH; Watkin JG; Liu C; Wohlreich MM; Raskin J
    BMC Psychiatry; 2005 Jan; 5():1. PubMed ID: 15631624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A subtle grey-matter increase in first-episode, drug-naive major depressive disorder with panic disorder after 6 weeks' duloxetine therapy.
    Lai CH; Hsu YY
    Int J Neuropsychopharmacol; 2011 Mar; 14(2):225-35. PubMed ID: 20663271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of pain on outcomes in a trial of duloxetine treatment of major depressive disorder.
    Arnold LM; Meyers AL; Sunderajan P; Montano CB; Kass E; Trivedi M; Wohlreich MM
    Ann Clin Psychiatry; 2008; 20(4):187-93. PubMed ID: 19034749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Duloxetine: A New Treatment for the Emotional and Physical Symptoms of Depression.
    Mallinckrodt CH; Goldstein DJ; Detke MJ; Lu Y; Watkin JG; Tran PV
    Prim Care Companion J Clin Psychiatry; 2003 Feb; 5(1):19-28. PubMed ID: 15156243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duloxetine in the treatment of major psychiatric and neuropathic disorders.
    Müller N; Schennach R; Riedel M; Möller HJ
    Expert Rev Neurother; 2008 Apr; 8(4):527-36. PubMed ID: 18416656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting treatment outcomes of major depressive disorder by early improvement in painful physical symptoms: a pooled analysis of double-blind, placebo-controlled trials of duloxetine.
    Tokuoka H; Nishihara M; Fujikoshi S; Yoshikawa A; Kuga A
    Neuropsychiatr Dis Treat; 2017; 13():2457-2467. PubMed ID: 29026309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Duloxetine for treating painful neuropathy or chronic pain.
    Lunn MP; Hughes RA; Wiffen PJ
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007115. PubMed ID: 19821395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of duloxetine in patients with an anxiety disorder, or with comorbid anxiety and major depressive disorder: a review of the literature.
    Mancini M; Perna G; Rossi A; Petralia A
    Expert Opin Pharmacother; 2010 May; 11(7):1167-81. PubMed ID: 20402555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of depressive symptoms and functional outcomes in patients with major depressive disorder treated with duloxetine versus placebo: primary outcomes from two trials conducted under the same protocol.
    Oakes TM; Myers AL; Marangell LB; Ahl J; Prakash A; Thase ME; Kornstein SG
    Hum Psychopharmacol; 2012 Jan; 27(1):47-56. PubMed ID: 22241678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Open-Label Pilot Study of Duloxetine in Patients With Irritable Bowel Syndrome and Comorbid Major Depressive Disorder.
    Lewis-Fernández R; Lam P; Lucak S; Galfalvy H; Jackson E; Fried J; Rosario M; de la Cruz AA; Sánchez-Lacay A; Díaz S; Schneier F
    J Clin Psychopharmacol; 2016 Dec; 36(6):710-715. PubMed ID: 27755218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Painful physical symptoms in depression: a clinical challenge.
    Wise TN; Fishbain DA; Holder-Perkins V
    Pain Med; 2007 Sep; 8 Suppl 2():S75-82. PubMed ID: 17714118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain.
    Pergolizzi JV; Raffa RB; Taylor R; Rodriguez G; Nalamachu S; Langley P
    Pain Pract; 2013 Mar; 13(3):239-52. PubMed ID: 22716295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.